Total planned funding: $233,895,873
Allocations
Countries/Regions
Eswatini | $233,895,873 |
Organizational Types
Private Contractor | $58,936,174 |
University | $55,336,610 |
NGO | $45,798,902 |
Own Agency | $28,193,944 |
Unknown | $25,931,828 |
Host Country Government Agency | $10,873,308 |
FBO | $6,188,454 |
Multi-lateral Agency | $1,303,840 |
Other USG Agency | $742,813 |
Implementing Agency | $590,000 |
Program Areas
Care | $76,952,372 |
Treatment | $46,910,907 |
Prevention | $42,384,676 |
Governance and Systems | $30,427,606 |
Testing | $19,733,780 |
Management and Operations | $17,486,532 |
Budget Codes
HTXS: Treatment: Adult Treatment | $37,562,260 |
HBHC: Care: Adult Care and Support | $34,854,559 |
HKID: Care: Orphans and Vulnerable Children | $22,030,895 |
HVCT: Testing: HIV Testing and Counseling | $19,733,780 |
HVMS: Management and Operations | $17,486,532 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $16,347,912 |
HVTB: Care: TB/HIV | $13,793,173 |
HVSI: Strategic Information | $12,835,161 |
OHSS: Health Systems Strengthening | $12,441,939 |
HVOP: Sexual Prevention: Other Sexual Prevention | $8,576,828 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $8,224,867 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $8,045,069 |
PDCS: Care: Pediatric Care and Support | $6,273,745 |
HLAB: Laboratory Infrastructure | $5,150,506 |
PDTX: Treatment: Pediatric Treatment | $4,927,028 |
HTXD: Treatment: ARV Drugs | $4,421,619 |
HMBL: Biomedical Prevention: Blood Safety | $1,190,000 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$48,324,075
Countries/Regions
Pact, Inc.:
$28,010,285
Countries/Regions
Not Available:
$21,532,842
Countries/Regions
USG Aggregated Agencies:
$14,983,192
Countries/Regions